Microdose Psychedelic Insights Launches First Wonderland Miami Psychedelic Conference
TORONTO–Microdose Psychedelic Insights are having their inaugural psychedelic medicine real-world event, Wonderland: Miami.
Wonderland: Miami will bring together an impressive group of global psychedelic medicine leaders, including scientists and researchers, investors and entrepreneurs, therapists and patients, government officials and media, all championing the growth of the psychedelic medicine industry.
After a successful year of over 20 industry-leading virtual conferences, including Psychedelic Capital and the Molecular Masterclass series, Wonderland: Miami will offer the industry a unique in-person convergence of business, science, music, and emerging technologies. Fostering creative and professional growth, Wonderland: Miami is the premier destination for the psychedelic industry.
(Mike Tyson will be a Key Speaker at Wonderland Miami)
The event is a thought-leadership platform and an opportunity to connect with influential leaders in science, policy, and business. It will also act as a launching pad for innovative content connected to the psychedelic medicine space, with musical showcases and documentary screenings, providing compelling entertainment and collaboration opportunities for attendees.
From Richard Skaife, the chair of Microdose and Founding Partner at The Conscious Fund: ”We launched Microdose at the start of what was to become a global lockdown for most of the world; quickly becoming a category leader in virtual events and sector insights for the psychedelic medicine industry. Jumping forward by 15 months as the world starts to return to an open economy we are delighted to bring our next event format to life: Wonderland, from Microdose.
(Rick Doblin from MAPS will be speaking)
Wonderland is all about real-life events. High-quality programming in some of the world’s most exciting locations and breathtaking venues. Wonderland in Miami will be for many the first time the industry has come together in person. We can’t wait to welcome you to Miami to see what we have created.”
Newly-announced Keynotes include:
- Robin Carhart-Harris, Ralph Metzner Distinguished Professor of Neurology & Psychiatry, Director Psychedelics Division, Neuroscape, UCSF
- Prof. David Nutt, Chief Research Officer, and Dr. Ben Sessa, Chief Medical Officer from Awakn Life Sciences Corp
- Dr. Matthew W. Johnson, Ph.D., Professor of Psychiatry and Behavioral Sciences at Johns Hopkins
- Rick Doblin, Ph.D. in conversation with Patrick Moher.
Newly-announced Sponsors include: Numinus, Mindset Pharma, Nushama, Braxia Scientific, Awakn Life Sciences, Negev Capital, Ambria Capital, Levitee Labs, MINDCURE, Zuber Lawler, Cybin, MNP LLP, Tryp Therapeutics, Entheo Digital, and Maya Health.
Among the Featured Speakers revealed today are Roger McIntyre, MD, FRCPC CEO & Director, Braxia Scientific BRAX (CNSX), Lamar Odom, former professional American basketball player, and Zappy Zapolin, Psychedelic Concierge. They will engage in a discussion on Ketamine: Past, Present and Future. A fireside chat moderated by Jemie Sae Koo will bring together Jason Silva, and Matt Zemon of Psychable discussing accessibility as the key to unlocking the transformational power of psychedelic medicine for society as a whole.
Daniel Carcillo, a Canadian former professional ice hockey left winger will sit down for a fireside chat with one of the greatest heavyweight boxers of all time, Mike Tyson.
Wonderland: Miami will collect an impressive group of global psychedelic medicine leaders, from scientists and researchers, investors and entrepreneurs, therapists and patients, government officials and media, all championing the growth of the psychedelic medicine industry. Organized into 30 programming tracks, the conference features Scientific, Financial, Business and Regulatory themes and a variety of presentation formats.
Newly-announced Featured Speakers include:
- Payton Nyquvest
- Jayashree Mitra
- Sharan Sidhu
- Michael Huttner
- Cody Shandraw
- Richard Skaife
- Ken Belotsky
- Charlie Finnie
- Ryan Zurrer
- Kelsey Ramsden
Newly-announced Featured Sessions include:
- Welcome Renaissance: Moving from the fringes of the research world and shaking off years of baggage from illicit recreational circles, scientists are making startling progress in legitimizing the medical potential of psychedelics.
- The Pathway to Federal Acceptance: Where are we now? Where are we heading?
- Psychedelic Capital Live: Entrepreneurs will be given an opportunity to pitch six Venture Capitalists and Investors in front of a live audience.
- Next-Generation Psychedelics: Let’s talk about advancements in R&D, trial designs, new compounds, regulatory affairs, patient engagement and new forms of partnerships.
- Microdosing: Fact or Fiction?: Does microdosing improve focus, creativity, and productivity? Are the touted effects fact or fiction?
- Patent Wars: Is the corporate domination of the industry a significant threat or an opportunity to decrease the stigma and take psychedelic medicine into mainstream healthcare?
- Finance and Psychedelics: Can consciousness and capitalism coexist?
- Investing the Shamanic Way: Shamanic protocol for making investment decisions.
- Psychedelics and Technology: What role does technology have to play in the safe and effective delivery of psychedelic medicine?
- Psychedelics & Sports
- The Spectrum of Psychedelics: Addressing the need for psychedelic equity, access, and affordability.
- Psychedelics and New Paradigms: Can psychedelic-assisted psychotherapy create a truly revolutionary paradigm shift in psychiatry?
- Psychedelics and the Current Medical Model
- The Last Mile: Taking a deeper look at Clinics & Retreats: How does the model work and why is it needed?
Wonderland: Miami looks like it is shaping up to be the premier destination for the psychedelic industry. The event will be a thought-leadership platform and an opportunity to connect with influential leaders in science, policy, and business.
(Adrienne Arsht Center for the Performing Arts, Miami is the venue of Miami Wonderland)
For more information, please visit their website.